SEC Filings

Form S-1/A
DURECT CORP filed this Form S-1/A on 09/01/2000
Document Outline
Entire Document (1001.9 KB)
Subdocument 1 - S-1/A - AMENDMENT #3 TO THE FORM S-1
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - PROSPECTUS (Subject to Completion)
Page 3 - N/A
Page 4 - TABLE OF CONTENTS
Page 5 - PROSPECTUS SUMMARY
Page 6 - N/A
Page 7 - THE OFFERING
Page 8 - Statement of Operations
Page 9 - RISK FACTORS
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 24 - USE OF PROCEEDS
Page 25 - CAPITALIZATION
Page 26 - DILUTION
Page 27 - Statement of Operations
Page 28 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - BUSINESS
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - N/A
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - MANAGEMENT
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - Section 423 of the Code, will be implemented by a series of overlapping
Page 63 - N/A
Page 64 - N/A
Page 65 - CERTAIN TRANSACTIONS
Page 66 - N/A
Page 67 - PRINCIPAL STOCKHOLDERS
Page 68 - N/A
Page 69 - N/A
Page 70 - DESCRIPTION OF CAPITAL STOCK
Page 71 - N/A
Page 72 - N/A
Page 73 - N/A
Page 74 - SHARES ELIGIBLE FOR FUTURE SALE
Page 75 - N/A
Page 76 - UNDERWRITING
Page 77 - N/A
Page 78 - N/A
Page 79 - LEGAL MATTERS
Page 80 - INDEX TO FINANCIAL STATEMENTS
Page 81 - REPORT OF INDEPENDENT AUDITORS
Page 82 - BALANCE SHEETS
Page 83 - N/A
Page 84 - N/A
Page 85 - N/A
Page 86 - STATEMENTS OF CASH FLOWS
Page 87 - NOTES TO FINANCIAL STATEMENTS
Page 88 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 89 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 90 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 91 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 92 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 93 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 94 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 95 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 96 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 97 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 98 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 99 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 100 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 101 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 102 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 103 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 104 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 105 - REPORT OF INDEPENDENT AUDITORS
Page 106 - BALANCE SHEETS
Page 107 - STATEMENTS OF OPERATIONS
Page 108 - STATEMENTS OF CASH FLOWS
Page 109 - NOTES TO FINANCIAL STATEMENTS
Page 110 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 111 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 112 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 113 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 114 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 115 - NOTES TO FINANCIAL STATEMENTS--(Continued)
Page 116 - UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS
Page 117 - DURECT CORPORATION AND ALZET
Page 118 - DURECT CORPORATION AND ALZET
Page 119 - N/A
Page 120 - N/A
Page 121 - Item 13. Other Expenses of Issuance and Distribution
Page 122 - Item 16. Exhibits and Financial Statement Schedules
Page 123 - N/A
Page 124 - Item 17. Undertakings
Page 125 - SIGNATURES
Page 126 - EXHIBIT INDEX
Page 127 - N/A
Subdocument 2 - EX-10.6 - SECOND AMENDMENT AND RESTATED DEVELOPMENT
Page 1 - EXHIBIT 10.6
Page 2 - TABLE OF CONTENTS
Page 3 - SECTION 1 - DEFINITIONS
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - Section 1.2, or (except to the extent agreed upon in writing by the parties) any
Page 9 - Section 8.1); and (C) Technical Information developed by ALZA outside the
Page 10 - N/A
Page 11 - Section 4.1.
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - SECTION 3 - DISCLOSURE OF INFORMATION
Page 16 - SECTION 4 - CONFIDENTIALITY OF INFORMATION
Page 17 - SECTION 5 - COMMERCIALIZATION RIGHTS
Page 18 - Section 6.3 for such
Page 19 - N/A
Page 20 - N/A
Page 21 - Section 2.5 or Exhibit F.
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - SECTION 6 - PAYMENTS
Page 29 - N/A
Page 30 - Section 5.1 shall terminate for such Product for such Subterritory.
Page 31 - SECTION 7 - PAYMENT PROCEDURES
Page 32 - N/A
Page 33 - SECTION 8 - OWNERSHIP AND USE OF PROGRAM INFORMATION
Page 34 - Section 8.1, provided such use, disclosure or license does not conflict with the
Page 35 - N/A
Page 36 - SECTION 10 - REPORTS OF ADVERSE REACTION
Page 37 - SECTION 11 - TERM AND TERMINATION; MODIFICATION OF RIGHTS
Page 38 - N/A
Page 39 - N/A
Page 40 - SECTION 12 - FORCE MAJEURE
Page 41 - N/A
Page 42 - SECTION 15 - ARBITRATION
Page 43 - Section 16.4 of this Agreement shall be valid and sufficient.
Page 44 - N/A
Page 45 - N/A
Page 46 - N/A
Page 47 - N/A
Page 48 - EXHIBIT A - Specified Anticancer Antigens for
Page 49 - CONFIDENTIAL
Page 50 - EXHIBIT B - Manufacturing Process Transfer
Page 51 - EXHIBIT C - Development Stages
Page 52 - EXHIBIT D - Countries of Sub-Territory C (Japan and East Asia)
Page 53 - EXHIBIT E - Cost Calculation for Purposes of Section 2.3(a)
Page 54 - EXHIBIT E-1 - Examples of Research Expenses
Page 55 - EXHIBIT F - Minimum Diligence Obligations
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - EXHIBIT G - Manufacturing Costs
Page 60 - EXHIBIT H - Amended and Restated Market Stand-Off Agreement
Page 61 - EXHIBIT I - Common Stock Purchase Agreement
Page 62 - EXHIBIT J - Warrant Agreement
Page 63 - N/A
Page 64 - N/A
Subdocument 3 - EX-10.7 - PRODUCT ACQUISITION AGREEMENT
Page 1 - EXHIBIT 10.7
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - Section 11.8 shall be solely at Buyer's expense, unless the prosecution or
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - EXHIBITS
Page 25 - GENERAL SUPPORT SERVICES AGREEMENT
Page 26 - Section 11.11 of the Acquisition Agreement.
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - EXHIBIT A
Page 33 - N/A
Page 34 - COATING SERVICES AGREEMENT
Page 35 - Section 11.11 of the Acquisition Agreement.
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - EXHIBIT A
Page 41 - NEW MODELS DEVELOPMENT AGREEMENT
Page 42 - N/A
Page 43 - N/A
Page 44 - ALZA CORPORATION DURECT CORPORATION
Page 45 - EXHIBIT A
Page 46 - EXHIBIT A-1
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - TRADEMARKS
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - Section 5.10:
Page 57 - N/A
Page 58 - N/A
Subdocument 4 - EX-10.20 - ASSET PURCHASE AGREEMENT
Page 1 - EXHIBIT 10.20
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - TABLE OF CONTENTS
Page 5 - DURECT CORPORATION
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - Section 9. The cash shall be deposited in a trust account pursuant to the Trust
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - Section 1445(f)(3) of the Code. There are no pending or, to Seller's knowledge,
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - Section 25102(f) of the California Corporate Securities Law of 1968, as amended,
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - Section 6 shall not have been satisfied or waived by Purchaser prior to October
Page 28 - N/A
Page 29 - N/A
Page 30 - Section 9.e, and that any such violation may cause substantial irreparable
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - EXHIBIT A
Page 37 - N/A
Page 38 - EXHIBIT B-1
Page 39 - N/A
Page 40 - EXHIBIT B-2
Page 41 - EXHIBIT C
Page 42 - EXHIBIT D
Page 43 - EXHIBIT E
Page 44 - EXHIBIT F
Page 45 - EXHIBIT G
Page 46 - EXHIBIT H
Page 47 - Section 3. Liquidation.
Page 48 - Section 5. Conversion. The holders of the Series B-1 Preferred Stock
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - Section 5 to be given to the holders of shares of Series B-1 Preferred Stock
Page 55 - Section 8. Status of Converted Stock. In the event any shares of Series
Page 56 - N/A
Page 57 - EXHIBIT I
Page 58 - EXHIBIT J
Page 59 - EXHIBIT K
Page 60 - EXHIBIT L
Page 61 - N/A
Page 62 - Section 9.b of the Purchase Agreement. The arbitration shall be conducted in San
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - N/A
Page 68 - N/A
Page 69 - DURECT CORPORATION
Page 70 - SELLER'S REPRESENTATIVE
Page 71 - EXHIBIT A
Page 72 - EXHIBIT B
Page 73 - EXHIBIT C
Page 74 - EXHIBIT M
Page 75 - DURECT CORPORATION
Page 76 - N/A
Page 77 - EXHIBIT N
Page 78 - N/A
Page 79 - Section 7(a) shall be binding upon the parties and their respective successors
Page 80 - N/A
Page 81 - DURECT CORPORATION
Subdocument 5 - EX-23.1 - CONSENT OF ERNST & YOUNG LLP
Page 1 - EXHIBIT 23.1